menu ☰
menu ˟

Public Health Well

Treatment goals, benefits in CKD, CVD may need revisiting

Matthew R. Weir PHILADELPHIA — Lack of data may lead to changes in treatment goals and benefits for patients with cardiovascular disease and chronic kidney disease in addition to diabetes, according to a speaker here. “We are missing a lot of important dat ...

Consider patient risk when targeting BP in diabetes

George L. Bakris Paul K. Whelton PHILADELPHIA — A debate continues over the optimal target for blood pressure management in type 2 diabetes with comorbid hypertension, with some experts pushing for a lower goal whenever possible, whereas others prefer a mo ...

High numbers of HIV-positive MSM not being tested for syphilis

Nearly one-third of sexually active HIV-positive men who have sex with men are not tested for syphilis at least annually, researchers reported in a recent study, calling the finding “concerning.” Alex de Voux, PhD, an Epidemiologist in the CDC’s Division o ...

PSNI warn over 'worrying increase' in holiday scams

Holidaymakers have been warned to be careful when booking hotel rooms online following an increase in "fake offers" on social media sites. ...

Thai boys rescued from cave mourn diver who died

The 12 boys and their football coach who were trapped in a cave complex in Thailand have been told of the death of a diver during the rescue operation, health officials have said. ...

Cardiologists should consider prescribing GLP1 agents for CVD prevention in type 2 diabetes

Ildiko Lingvay PHILADELPHIA — Although endocrinologists may routinely prescribe the newer classes of diabetes drugs approved for cardiovascular risk reduction, cardiologists and primary care providers should also consider using these agents for patients wi ...

VIDEO: Focus on heart failure prevention warranted in patients with diabetes

PHILADELPHIA — In this video exclusive, Javed Butler, MD, MPH, MBA, FACC, FAHA, the Patrick A. Lehan Professor and chairman of the department of medicine at University of Mississippi, emphasizes the importance of heart failure prevention in patients with d ...

Ophthalmology week in review

Here are some recent top articles on Healio.com/OSN:   FDA accepts NDA for loteprednol etabonate ophthalmic gel 0.38% A new drug application for Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel 0.38% has been accepted by the FDA. Read more. ...

VIDEO: Synthetic implant for great toe arthritis linked with ‘excellent’ results after 5.8 years

BOSTON — At the American Orthopaedic Foot & Ankle Society Annual Meeting, Judith F. Baumhauer, MD, MS, MPH, discusses a study that examined the 5.8-year survivorship, pain, functional outcomes and safety parameters of a synthetic implant that was place ...

US Oncology Network names chief surgical officer

Loren Rourke   The US Oncology Network appointed breast surgeon Loren Rourke, MD, MHCM, as its chief surgical officer. In this newly created position, Rourke will spearhead the network’s surgical programs and collaborative approach to cancer care. “I am th ...

Lifestyle changes necessary for mitigating cardiometabolic risk

Christos S. Mantzoros PHILADELPHIA — Lifestyle modifications, such as adherence to a healthy diet, smoking cessation and adequate exercise, are a must to help reduce cardiometabolic disease risk, according to a presenter here. “This is a very important top ...

Sean Cox regains consciousness months after assault

Sean Cox, the Liverpool fan from Dunboyne who was the victim of a serious assault outside Anfield prior to a Champions League game, has regained consciousness. ...

We baby boomers are an easy target | letters

Rather than blaming older people for everything from being a tax on the young to shoring up wealth, look at all the good we have done I would like to point out to Phillip Inman that most baby boomers and those who are older worked hard for their money and ...

Heatwave causes spike in insect bite calls to NHS

Horsefly bites are painful and can lead to a skin infection that may require antibiotics, say doctors. ...

VIDEO: Newer diabetes agents join cardiologists' arsenal

PHILADELPHIA — In this video exclusive, Darren K. McGuire, MD, MHSc, professor of medicine in the division of cardiology, Dallas Heart Ball Chair for Research on Heart Disease in Women and Distinguished Teaching Professor at the University of Texas Southwe ...

In diabetes with CVD, traditional risk factor modification remains top priority

Jane E.B. Reusch PHILADELPHIA — Studies demonstrating the dual efficacy of antihyperglycemic agents on both glucose and cardiovascular disease risk should change the treatment landscape only in people with high CV risk or established disease, according to ...

Mixed results seen in cardiovascular outcome trials of diabetes agents

PHILADELPHIA — Although some of the leading safety trials of newer anti-hyperglycemic drugs in patients with type 2 diabetes have shown reductions in cardiovascular risks, others have yielded mixed results, according to a presenter at the Heart in Diabetes ...

Consumer technology poised to improve diabetes, CVD management

George Grunberger PHILADELPHIA — Wearable technologies may soon play a larger role in prevention and management of diabetes and heart disease, according to a speaker here. As cardiovascular disease is the leading cause of death among all adults with diabet ...

Among ESBL-producing organisms, K. pneumoniae may be deadlier than E. coli

In a retrospective evaluation of patients at a St. Louis hospital, extended-spectrum beta-lactamase-producing — or ESBL-producing — Klebsiella pneumoniae was associated with a marginally increased risk for 30-day mortality compared with ESBL-producing Esch ...

VIDEO: Heart failure presents unique challenges in diabetes

PHILADELPHIA — In this video exclusive, Mikhail Kosiborod, MD, FACC, FAHA, cardiologist at Saint Luke’s Mid America Heart Institute, professor of medicine at the University of Missouri-Kansas City School of Medicine and co-chair of the Heart in Diabetes me ...

IPH Logo

Filter by content type: